Agios Pharmaceuticals, Inc.AGIONASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank86
3Y CAGR-28.1%
5Y CAGR+54.6%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
-28.1%/yr
vs +75.8%/yr prior
5Y CAGR
+54.6%/yr
Recent deceleration
Acceleration
-104.0pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
8.8x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $58.34M | -94.9% |
| 2024 | $1.14B | +2802.9% |
| 2023 | $39.40M | -74.9% |
| 2022 | $157.25M | +617.8% |
| 2021 | $21.91M | +231.4% |
| 2020 | $6.61M | -55.5% |
| 2019 | $14.86M | -9.7% |
| 2018 | $16.45M | +168.6% |
| 2017 | $6.12M | +143.6% |
| 2016 | $2.51M | - |